Cargando…
Chemotherapeutic effect of a novel temozolomide analog on nasopharyngeal carcinoma in vitro and in vivo
BACKGROUND: Many patients with nasopharyngeal carcinoma (NPC) face poor prognosis. Due to its hidden anatomical location, the tumor is usually diagnosed quite late, and despite initially successful treatment with radiation and cisplatin, many patients will relapse and succumb to the disease. New tre...
Autores principales: | Chen, Thomas C., Cho, Hee-Yeon, Wang, Weijun, Wetzel, Stephanie J., Singh, Anupam, Nguyen, Jenny, Hofman, Florence M., Schönthal, Axel H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539921/ https://www.ncbi.nlm.nih.gov/pubmed/26282951 http://dx.doi.org/10.1186/s12929-015-0175-6 |
Ejemplares similares
-
NEO412: A temozolomide analog with transdermal activity in melanoma in vitro and in vivo
por: Swenson, Steve, et al.
Publicado: (2018) -
Pharmacokinetic properties of the temozolomide perillyl alcohol conjugate (NEO212) in mice
por: Cho, Hee-Yeon, et al.
Publicado: (2020) -
Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas
por: Minea, Radu O., et al.
Publicado: (2020) -
Rare Stochastic Expression of O6-Methylguanine- DNA Methyltransferase (MGMT) in MGMT-Negative Melanoma Cells Determines Immediate Emergence of Drug-Resistant Populations upon Treatment with Temozolomide In Vitro and In Vivo
por: Chen, Thomas C., et al.
Publicado: (2018) -
Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo
por: Pyrko, Peter, et al.
Publicado: (2006)